IP Library › Granted Patent US 7,803,612
Granted Patent B2
US 7,803,612 · App. 11/404,534 · Granted Sep 28, 2010

Nipah virus vaccines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,612
App. No.
11/404,534
Granted
Sep 28, 2010
Kind
B2
Abstract

The present invention relates to recombinant anti-Nipah virus vaccines and the administration of such vaccines to animals, advantageously pigs. Advantageously, the anti-Nipah virus vaccine may comprise a recombinant avipox virus containing a Nipah virus glycoprotein gene. The invention encompasses methods of vaccinating animals, advantageously pigs, by administration of anti-Nipah virus vaccines that may comprise a recombinant avipox virus that may contain a Nipah virus glycoprotein gene.

Claims (2)

1. An expression vector comprising a polynucleotide having the sequence as set forth in SEQ ID NO:27 or SEQ ID NO:28.

2. An expression vector comprising a polynucleotide having the sequence as set forth in SEQ ID NO:24 or SEQ ID NO:25.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2015
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 035013/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2006
From: AUDONNET, JEAN CHRISTOPHE FRANCIS
To: MERIAL LIMITED
Reel/Frame 018036/0139 →